These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
65 related articles for article (PubMed ID: 22738945)
1. Treating pediatric nonalcoholic fatty liver disease with cysteamine: is adiponectin the key? Xanthakos SA; Kohli R J Pediatr; 2012 Oct; 161(4):579-81. PubMed ID: 22738945 [No Abstract] [Full Text] [Related]
2. The effect of cysteamine bitartrate on adiponectin multimerization in non-alcoholic fatty liver disease and healthy subjects. Dohil R; Meyer L; Schmeltzer S; Cabrera BL; Lavine JE; Phillips SA J Pediatr; 2012 Oct; 161(4):639-45.e1. PubMed ID: 22633783 [TBL] [Abstract][Full Text] [Related]
3. Tissue-specific effect of dietary cysteamine on expression of adiponectin receptors in rats. Xu J; Shao W; Chi H; Tan Y; Zhao R J Agric Food Chem; 2007 Sep; 55(19):7968-73. PubMed ID: 17696487 [TBL] [Abstract][Full Text] [Related]
4. WSF-P-1, a novel AMPK activator, promotes adiponectin multimerization in 3T3-L1 adipocytes. Wang Y; Zhang Y; Wang Y; Peng H; Rui J; Zhang Z; Wang S; Li Z Biosci Biotechnol Biochem; 2017 Aug; 81(8):1529-1535. PubMed ID: 28608766 [TBL] [Abstract][Full Text] [Related]
5. Inhibition of peripubertal sheep mammary gland development by cysteamine through reducing progesterone and growth factor production. Zhao Y; Feng Y; Zhang H; Kou X; Li L; Liu X; Zhang P; Cui L; Chu M; Shen W; Min L Theriogenology; 2017 Feb; 89():280-288. PubMed ID: 28043364 [TBL] [Abstract][Full Text] [Related]
6. Enteric-coated cysteamine for the treatment of paediatric non-alcoholic fatty liver disease. Dohil R; Schmeltzer S; Cabrera BL; Wang T; Durelle J; Duke KB; Schwimmer JB; Lavine JE Aliment Pharmacol Ther; 2011 May; 33(9):1036-44. PubMed ID: 21395631 [TBL] [Abstract][Full Text] [Related]
7. Activation of AMPK by berberine promotes adiponectin multimerization in 3T3-L1 adipocytes. Li Y; Wang P; Zhuang Y; Lin H; Li Y; Liu L; Meng Q; Cui T; Liu J; Li Z FEBS Lett; 2011 Jun; 585(12):1735-40. PubMed ID: 21536037 [TBL] [Abstract][Full Text] [Related]
8. Adiponectin self-regulates its expression and multimerization in adipose tissue: an autocrine/paracrine mechanism? Lin H; Li Z Med Hypotheses; 2012 Jan; 78(1):75-8. PubMed ID: 22014406 [TBL] [Abstract][Full Text] [Related]
9. Dimerization of adiponectin receptor 1 is inhibited by adiponectin. Kosel D; Heiker JT; Juhl C; Wottawah CM; Blüher M; Mörl K; Beck-Sickinger AG J Cell Sci; 2010 Apr; 123(Pt 8):1320-8. PubMed ID: 20332107 [TBL] [Abstract][Full Text] [Related]
10. Transcriptional and post-translational regulation of adiponectin. Liu M; Liu F Biochem J; 2009 Dec; 425(1):41-52. PubMed ID: 20001961 [TBL] [Abstract][Full Text] [Related]
11. A highly conserved tryptophan in the N-terminal variable domain regulates disulfide bond formation and oligomeric assembly of adiponectin. Radjainia M; Huang B; Bai B; Schmitz M; Yang SH; Harris PW; Griffin MD; Brimble MA; Wang Y; Mitra AK FEBS J; 2012 Jul; 279(14):2495-507. PubMed ID: 22583869 [TBL] [Abstract][Full Text] [Related]
12. Resveratrol Cardioprotection Against Myocardial Ischemia/Reperfusion Injury Involves Upregulation of Adiponectin Levels and Multimerization in Type 2 Diabetic Mice. Yang Q; Wang HC; Liu Y; Gao C; Sun L; Tao L J Cardiovasc Pharmacol; 2016 Oct; 68(4):304-312. PubMed ID: 27332935 [TBL] [Abstract][Full Text] [Related]
13. Effect of thiol-containing molecule cysteamine on the induction of inducible nitric oxide synthase in hepatocytes. Ozaki T; Kaibori M; Matsui K; Tokuhara K; Tanaka H; Kamiyama Y; Nishizawa M; Ito S; Okumura T JPEN J Parenter Enteral Nutr; 2007; 31(5):366-71; discussion 371-2. PubMed ID: 17712144 [TBL] [Abstract][Full Text] [Related]
14. [Action of cysteamine on ultrastructural changes in the liver cell of the rabbit subjected to total-body roentgen irradiation]. Birarelli B; Levis F Radiobiol Radioter Fis Med; 1966; 21(2):73-85. PubMed ID: 5944697 [No Abstract] [Full Text] [Related]
16. [Regulation of threonine deaminase activity in the rat liver. II. Inhibition due to cysteamine]. Lusini P; Di Stefano A; Di Bello L; Pagani R; Marinello E Boll Soc Ital Biol Sper; 1975 Nov; 51(21):1565-8. PubMed ID: 1231843 [No Abstract] [Full Text] [Related]
17. Cysteamine: an old drug with new potential. Besouw M; Masereeuw R; van den Heuvel L; Levtchenko E Drug Discov Today; 2013 Aug; 18(15-16):785-92. PubMed ID: 23416144 [TBL] [Abstract][Full Text] [Related]
18. Serum total adiponectin in nonalcoholic fatty liver disease: a systematic review and meta-analysis. Polyzos SA; Toulis KA; Goulis DG; Zavos C; Kountouras J Metabolism; 2011 Mar; 60(3):313-26. PubMed ID: 21040935 [TBL] [Abstract][Full Text] [Related]
19. Fatty Acid Cysteamine Conjugates as Novel and Potent Autophagy Activators That Enhance the Correction of Misfolded F508del-Cystic Fibrosis Transmembrane Conductance Regulator (CFTR). Vu CB; Bridges RJ; Pena-Rasgado C; Lacerda AE; Bordwell C; Sewell A; Nichols AJ; Chandran S; Lonkar P; Picarella D; Ting A; Wensley A; Yeager M; Liu F J Med Chem; 2017 Jan; 60(1):458-473. PubMed ID: 27976892 [TBL] [Abstract][Full Text] [Related]
20. [Fatty acids and phospholipids in repair tissue of a fracture site in irradiated mice effect of cysteamine]. Drouet J; Dupont J; Nguyen TL; Fournié J; Goyffon M C R Seances Soc Biol Fil; 1972; 166(12):1585-91. PubMed ID: 4665257 [No Abstract] [Full Text] [Related] [Next] [New Search]